Pacira Pharmaceuticals reported $714M in Loan Capital for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Amerisourcebergen ABC:US USD 4.63B 7.77M
Astellas Pharma 4503:JP JPY 82.39B 29.23B
Bristol Myers Squibb BMY:US USD 36.97B 141M
Endo International Ordinary Shares ENDP:US USD 1.42M 8.05B
Horizon Pharma HZNP:US USD 2.55B 1.85M
Ironwood Pharmaceuticals IRWD:US USD 395.85M 399K
Lannett LCI:US USD 619.34M 4.39M
Omeros OMER:US USD 439.82M 125.46M
Pacira Pharmaceuticals PCRX:US USD 714M 7.88M
Perrigo Ordinary Shares PRGO:US USD 4.08B 8.6M
Revance Therapeutics RVNC:US USD 378.89M 506K
Teva Pharmaceutical TEVA:IT USD 18.5B 1.87B
Xeris Pharmaceuticals Inc XERS:US USD 138.51M 439K
Zoetis ZTS:US USD 5.21B 11M